FDA 483 - Vasomedical Inc - January 09, 2023

An FDA inspection of Vasomedical Inc in Plainview, NY, from January 4-9, 2023, revealed a significant quality system deficiency. The firm failed to formally appoint a management representative responsible for ensuring quality system requirements are met and reporting on its performance. This indicates a lack of documented oversight in a critical area of quality management.